Tizona Therapeutics Investors

28 investors on Angel Roster list Tizona Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, the United Kingdom and Ireland.

Investors are matched on the company name in their portfolio, so companies that share the name Tizona Therapeutics can appear together.

Investors listed
28
With verified email
50%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 28 Tizona Therapeutics investors

The most complete profiles first. Showing 28 of 28.

  • Caroline G.Verified

    Venture Capital, Investor · Ireland

    SeedHealth CareWearablesWellnessWomen Founded

    Portfolio: Shoulder Innovations, ProVerum Medical, Medisix Therapeutics, Gemini Therapeutics and 23 more

    Verified email available

  • Ken HaasVerified

    Venture Capital, Advisor, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Nina KjellsonVerified

    Venture Capital, Angel/Individual, Investor · United States

    Series BSeries ABiotechnologyElectronic Health Records (EHR)Health and Hospital ServicesConsumer Internet

    Portfolio: Labrys Biologics, Eiger BioPharmaceuticals, Fluidigm, Ocera Therapeutics and 10 more

    Verified email available

  • andrew sinclairVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Brian GoodmanVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Doug FisherVerified

    Venture Capital · United States

    Health CareHospitalsE-commerceAccounting

    Portfolio: Crowdpac, Welcome Software, Cuyana, Joyus and 52 more

    Verified email available

  • Karen WilsonVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsE-commerceAccounting

    Portfolio: Crowdpac, Welcome Software, Cuyana, Joyus and 51 more

    Verified email available

  • Kenneth NoonanVerified

    Venture Capital · Singapore

    Health CareWearablesWellnessWomen Founded

    Portfolio: Shoulder Innovations, Medisix Therapeutics, Gemini Therapeutics, Locanabio and 22 more

    Verified email available

  • Luke EvninVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Shelley ChuVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Shinichiro FuseVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Stephen HolmesVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsE-commerceAccounting

    Portfolio: Crowdpac, Welcome Software, Cuyana, Joyus and 51 more

    Verified email available

  • Tim HainesVerified

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Todd FoleyVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Bali Muralidhar

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more

    Contact details available

  • Brian Gallagher, Jr.

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more

    Contact details available

  • Ed Hurwitz

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more

    Contact details available

  • Jason Lettmann

    Venture Capital, Investor · Ireland

    SeedHealth CareWearablesWellnessWomen Founded

    Portfolio: Shoulder Innovations, Medisix Therapeutics, Gemini Therapeutics, Locanabio and 27 more

    Contact details available

  • Kurt von Emster

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedInvestment ManagementLife Science

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Mike Carusi

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWellnessWomen Founded

    Portfolio: Shoulder Innovations, Medisix Therapeutics, Gemini Therapeutics, Locanabio and 24 more

    Contact details available

  • Stephen Curtis

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Vin Miles

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Christiana Bardon M.D.

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsInvestment ManagementLife Science

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • John Heard

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Leigh Zawel

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Sarah Shackelton

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Vinay Bhaskar

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Wen Qi Ho

    Venture Capital · Singapore

    Health CareWearablesWellnessWomen Founded

    Portfolio: Shoulder Innovations, Medisix Therapeutics, Gemini Therapeutics, Locanabio and 22 more

    Contact details available

Frequently asked questions

How many Tizona Therapeutics investors are on Angel Roster?

Angel Roster lists 28 Tizona Therapeutics investors. 14 of them (50%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (28), Private Equity Firms (16) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Tizona Therapeutics investors invest in?

Among those that list a stage, the most common are Series B (7), Seed (5) and Series A (1).

Where are Tizona Therapeutics investors based?

Most are based in the United States (19), the United Kingdom (5) and Ireland (2).

Which companies have Tizona Therapeutics investors backed?

The most-backed portfolio companies among them are Proteon Therapeutics (19), Chiasma (19), Valeritas (19), Atsena Therapeutics (15) and Avedro (13).

How do I contact Tizona Therapeutics investors?

Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.